Locations
Indianapolis, IN, USA
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Seed
founded in
2017
Toralgen, Inc. is a preclinical stage biopharmaceutical company focused on the development and commercialization of human therapeutics, particularly for diabetes and autoimmune disorders. Their unique poly-bile nanoparticle platform addresses the challenges of oral drug delivery, allowing for effective and efficient absorption of biologics through a simple nanopill technology. This innovative approach not only enhances drug bioavailability but also aims to improve patient compliance by replacing painful injections with easy-to-swallow pills. With a well-funded background and a team boasting over 150 years of combined experience in pharmaceutical research, Toralgen is positioned as a top emerging drug delivery startup, actively collaborating with pharmaceutical partners for upcoming trials.
Is this your company?
Something looks off?